What is ECMO Advantage?
ECMO Advantage operates as a specialized healthcare services organization dedicated to the advancement of extracorporeal membrane oxygenation (ECMO) programs. The company provides comprehensive support, including program development, clinical training, and the staffing of specialized professionals for hospitals and healthcare systems. By offering expert guidance and operational assistance, ECMO Advantage empowers medical facilities to build and strengthen their ECMO capabilities, ultimately improving the safety, efficiency, and clinical effectiveness of critical cardiopulmonary life-support interventions.
How much funding has ECMO Advantage raised?
ECMO Advantage has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ECMO Advantage
PPP
Public-Private Partnership
What's next for ECMO Advantage?
With a substantial late-stage funding context, ECMO Advantage is poised for continued expansion and enhancement of its service offerings. The recent strategic investment likely signals a phase of scaling operations, potentially involving the broadening of its client base, further development of its training methodologies, or the integration of new technologies to support ECMO programs. The company's focus on a critical, high-demand medical service suggests a trajectory aimed at solidifying its leadership in providing specialized staffing and expertise to healthcare providers navigating the complexities of advanced life support.
See full ECMO Advantage company page
